Evidence map›Paper›PMID 41932903›Full record

ArticleNature communications2026

Distinct mechanisms of replication stress induced by oncogenic RAS and cyclin E1 converge on R-loop-dependent fork reversal.

Anna Oravetzova, Marketa Dvorakova, Anca-Irina Mihai, Martin Andrs, Margarita Sobol, Anton Zuev, Kaustubh Shukla, Barbora Boleslavska, Vinicio Rosano, Christiane König and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna Oravetzova *Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0003-2483-3739
Marketa Dvorakova *Institute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.
Anca-Irina Mihai *Institute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4194-3780
Martin AndrsInstitute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.
Margarita SobolLaboratory of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0003-3363-9460
Anton ZuevLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0003-3058-9429
Kaustubh ShuklaLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0001-7921-4519
Barbora BoleslavskaLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.
Vinicio RosanoInstitute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.
Christiane KönigInstitute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.
Jiri ProkesInstitute of Molecular Cancer Research, University of Zurich, Strickhofstrasse 40a, Zurich, Switzerland.
Hana HanzlikovaLaboratory of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0001-7235-7269
Libor MacurekLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.
Jana DobrovolnaLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0003-2412-2080
Pavel JanscakLaboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, Czech Republic. pjanscak@imcr.uzh.ch.ORCID http://orcid.org/0000-0002-1748-7789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activated oncogenes elicit genomic instability by inducing DNA replication stress. Here we show that replication fork reversal and chromosome mis-segregation induced by oncogenic RAS (HRASV12) or cyclin E1 overexpression are largely caused by co-transcriptional RNA:DNA hybrids (R-loops) formed during S-phase. Furthermore, we demonstrate that replication stress induced by HRASV12, but not cyclin E1, is driven by reactive oxygen species (ROS) in a manner dependent on the replisome-associated ROS sensor peroxiredoxin 2 (PRDX2) and is linked to PRDX2-mediated release of the fork acceleration factor TIMELESS from the replisome. Inhibition of fork reversal in cells overexpressing HRASV12 or cyclin E1 induces unrestrained DNA synthesis mediated by the MUS81 endonuclease and the primase-polymerase PRIMPOL, thereby promoting proper chromosome segregation in mitosis. These results establish PRIMPOL repriming as part of the MUS81-dependent replication restart mechanism that operates at sites of R-loop-mediated transcription-replication conflicts to maintain genomic stability. Furthermore, our data indicate that, despite their protective role during S-phase, persistent reversed forks impair chromosome segregation in mitosis, potentially leading to DNA breaks and chromosomal rearrangements.

Indexed as

Cyclin EDNA ReplicationOncogene Proteinsras ProteinsR-Loop StructuresDNA-Directed DNA PolymeraseGenomic InstabilityHumansReactive Oxygen SpeciesS PhaseCCNE1 protein, humanCyclin EDNA-Directed DNA PolymeraseOncogene Proteinsras ProteinsReactive Oxygen Species

Identifiers

PMID41932903
PMCPMC13219726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.